Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation
- PMID: 18504100
- DOI: 10.1016/j.avsg.2008.02.017
Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation
Abstract
Stimulation of vascular growth to treat limb ischemia is promising, and early results obtained from uncontrolled clinical trials using angiogenic agents, e.g., vascular endothelial growth factor, led to high expectations. However, negative results from recent placebo-controlled trials warrant further research. Here, current insights into mechanisms of vascular growth in the adult, in particular the role of angiogenic factors, the immune system, and bone marrow, were reviewed, together with modes of its therapeutic stimulation and results from recent clinical trials. Three concepts of vascular growth have been described to date-angiogenesis, vasculogenesis, and arteriogenesis (collateral artery growth)-which represent different aspects of an integrated process. Stimulation of arteriogenesis seems clinically most relevant and has most recently been attempted using autologous bone marrow transplantation with some beneficial results, although the mechanism of action is not completely understood. Better understanding of the highly complex molecular and cellular mechanisms of vascular growth may yet lead to meaningful clinical applications.
Similar articles
-
Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials.Trends Cardiovasc Med. 2004 Nov;14(8):295-300. doi: 10.1016/j.tcm.2004.09.001. Trends Cardiovasc Med. 2004. PMID: 15596105 Review.
-
Angiogenesis and gene therapy in man: dream or reality?Drugs. 1999;59 Spec No:33-6. Drugs. 1999. PMID: 10548390 Review.
-
A balancing act: therapeutic approaches for the modulation of angiogenesis.Curr Opin Investig Drugs. 2006 Mar;7(3):243-50. Curr Opin Investig Drugs. 2006. PMID: 16555684
-
Therapeutic angiogenesis. Devising new strategies based on past experiences.Basic Res Cardiol. 2004 Mar;99(2):121-32. doi: 10.1007/s00395-004-0447-x. Epub 2003 Oct 30. Basic Res Cardiol. 2004. PMID: 14963670 Review.
-
[Therapeutic angiogenesis of critical lower limb ischemia. Review of the literature and prospects of research on stem cells].Ital Heart J Suppl. 2004 Jan;5(1):1-13. Ital Heart J Suppl. 2004. PMID: 15253139 Review. Italian.
Cited by
-
Cystathionine γ-lyase regulates arteriogenesis through NO-dependent monocyte recruitment.Cardiovasc Res. 2015 Sep 1;107(4):590-600. doi: 10.1093/cvr/cvv198. Epub 2015 Jul 20. Cardiovasc Res. 2015. PMID: 26194202 Free PMC article.
-
Cell Therapy: Types, Regulation, and Clinical Benefits.Front Med (Lausanne). 2021 Nov 22;8:756029. doi: 10.3389/fmed.2021.756029. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34881261 Free PMC article. Review.
-
REX-001, a BM-MNC Enriched Solution, Induces Revascularization of Ischemic Tissues in a Murine Model of Chronic Limb-Threatening Ischemia.Front Cell Dev Biol. 2020 Dec 9;8:602837. doi: 10.3389/fcell.2020.602837. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33363160 Free PMC article.
-
Ixmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophages.Stem Cell Res Ther. 2013 Nov 1;4(6):134. doi: 10.1186/scrt345. Stem Cell Res Ther. 2013. PMID: 24405629 Free PMC article.
-
The Hyperoxic-Hypoxic Paradox.Biomolecules. 2020 Jun 25;10(6):958. doi: 10.3390/biom10060958. Biomolecules. 2020. PMID: 32630465 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources